rs531470904
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152347.5(EFCAB13):c.461A>G(p.Tyr154Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,607,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152347.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFCAB13 | ENST00000331493.7 | c.461A>G | p.Tyr154Cys | missense_variant | Exon 8 of 25 | 1 | NM_152347.5 | ENSP00000332111.2 | ||
EFCAB13 | ENST00000517484.5 | c.461A>G | p.Tyr154Cys | missense_variant | Exon 8 of 22 | 2 | ENSP00000430048.1 | |||
EFCAB13 | ENST00000517310.5 | c.17A>G | p.Tyr6Cys | missense_variant | Exon 9 of 11 | 2 | ENSP00000466136.1 | |||
EFCAB13 | ENST00000520776.5 | n.595A>G | non_coding_transcript_exon_variant | Exon 6 of 14 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246000Hom.: 0 AF XY: 0.0000301 AC XY: 4AN XY: 133106
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1454978Hom.: 0 Cov.: 29 AF XY: 0.0000166 AC XY: 12AN XY: 723676
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.461A>G (p.Y154C) alteration is located in exon 8 (coding exon 5) of the EFCAB13 gene. This alteration results from a A to G substitution at nucleotide position 461, causing the tyrosine (Y) at amino acid position 154 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at